The Journal of Organic Chemistry
Article
1237 (sh), 1231 (m), 1231 (m), 1126 (vw), 1112 (sh), 1108 (vw),
1102 (vw), 1080 (w), 1070 (w), 1032 (w), 1016 (w), 976 (vw), 907
(m), 841 (sh), 836 (vw), 811 (w), 800 (m), 758 (w), 735 (m), 710
(sh), 705 (vw), 661 (m), 635(vw),628 (sh), 626 (sh), 598 (vw), 533
(m) cm−1. ESI-MS (pos.) m/z (%): 293.2 [M + H+]+ (100), 585.4 [2·
M + H+]+ (16).
colorless powder (0.0884 g, 0.20 mmol, yield 69%). Mp: 162−164
°C. Anal. Calcd for C21H27IN2·0.8H2O: C, 56.20; H, 6.42; N 6.24.
Found: C, 56.25; H, 6.43; N, 6.22. HRMS (ESI/TOF) m/z: M+
1
Calcd for C21H27N2 307.2169; Found 307.2175. H NMR (CDCl3,
500 MHz): δ 10.37 (s, 1H), 7.40 (s, 4H), 7.29 (s, 1H), 7.21 (s, 1H),
5.49 (s, 2H), 4.09 (s, 3H), 2.09 (um, 3H), 1.88 (m, 6H), 1.76 (m,
6H). 13C{1H} NMR (CDCl3, 126 MHz): δ 153.3, 138.1, 129.6, 129.1,
126.3, 123.5, 122.0, 53.9, 43.2, 37.4, 36.8, 36.5, 29.0. IR (KBr): 3440
(m), 3166 (vw), 3131 (vw), 3096 (vw), 3081 (w), 2964 (w), 2925
(sh), 2910 (sh), 2903 (sh), 2889 (sh), 2877 (s), 2849 (s), 1567 (m),
1561 (sh), 1554 (sh), 1514 (w), 1507 (s), 1457 (sh), 1450 (w), 1420
(sh), 1416 (w), 1409 (vw), 1361 (w), 1356 (sh), 1348 (w), 1342 (w),
1332 (vw), 1321 (vw), 1319 (sh), 1273 (vw), 1160 (sh), 1144 (w),
1107 (w), 1104 (sh), 1101 (sh), 1034 (vw), 1022 (w), 1018 (sh), 976
(vw), 862 (vw), 852 (w), 813 (m), 804 (m), 774 (w), 768 (w), 762
(sh), 758 (w), 745 (sh), 710 (w), 691 (w), 664 (sh), 657 (w), 623
(m), 614 (w), 593 (vw), 539 (m) cm−1. ESI-MS (pos.) m/z (%):
307.1 [M+]+ (100).
1-(3-(1-Adamantyl)benzyl)-1H-imidazole (4b) was prepared
following an analogous procedure as described for 4a. However, the
starting mixture of bromides 3a and 3b was prepared by method B.
This mixture of 3a and 3b (0.4165 g, 1.36 mmol, 3a:3b = 1:2)
provided a colorless microcrystalline powder of 4b (0.080 g, 0.27
mmol, yield 20%). Mp: 136−139 °C. Anal. Calcd for C20H24N2: C,
82.15; H, 8.27; N, 9.58. Found: C, 81.93; H, 8.35; N, 9.48. 1H NMR
(CDCl3, 500 MHz): δ 7.78 (s, 1H), 7.34 (um, 1H), 7.30 (m, 1H),
7.17 (s, 1H), 7.12 (s, 1H), 6.97 (um, 1H), 6.93 (s, 1H), 5.15 (s, 2H),
2.09 (um, 3H), 1.87 (m, 6H), 1.76 (m, 6H). 13C{1H} NMR (CDCl3,
126 MHz): δ 152.6, 137.3, 135.4, 129.0, 128.4, 125.3, 124.8, 124.2,
119.7, 51.7, 43.2, 36.8, 36.4, 29.0. IR (KBr): 3100 (vw), 3024 (vw),
2902 (vs), 2846 (vs), 1606 (w), 1587 (vw), 1504 (m), 1449 (w),
1392 (vw), 1367 (vw), 1355 (vw), 1343 (w), 1318 (w), 1278 (w),
1261 (vw),1225 (w), 1184 (vw), 1169 (vw), 1106 (m), 1090 (m),
1073 (m), 1049 (w), 1027 (m), 975 (w), 905 (w), 865 (vw), 815
(vw), 806 (w), 761 (w), 736 (s), 699 (m), 663 (m), 628 (w), 634
(sh), 547 (vw), 442 (vw) cm−1. ESI-MS (pos.) m/z (%): 293.2 [M +
H+]+ (100), 585.4 [2·M + H+]+ (13).
1-(3-(1-Adamantyl)benzyl)-1H-imidazolium iodide (5b) was
prepared from compound 4b (0.0556 g, 0.19 mmol) to yield a
colorless powder (0.0509 g, 0.12 mmol, yield 63%). Mp: 171−173
°C. Anal. Calcd for C21H27IN2: C, 58.07; H, 6.27; N, 6.45. Found: C,
1
57.94; H, 6.36; N, 6.39. H NMR (DMSO-d6, 500 MHz): δ 9.20 (s,
1H), 7.81 (um, 1H), 7.70 (um, 1H), 7.48 (um, 1H), 7.38 (um, 1H),
7.35 (m, 1H), 7.20 (um, 1H), 5.39 (s, 2H), 3.86 (s, 3H), 2.07 (um,
3H), 1.86 (m, 6H), 1.74 (m, 6H). 13C{1H} NMR (DMSO-d6, 126
MHz): δ 151.8, 136.5, 134.5, 128.7, 125.4, 125.2, 125.0, 124.0, 122.3,
52.2, 42.5, 36.1, 35.9, 35.8, 28.2. IR (KBr): 3418 (vw), 3142 (vw),
3126 (vw), 3076 (vs), 3052 (sh), 2971 (w), 2923 (vs), 2911 (vs),
2895 (vs), 2848 (vs), 1605 (w), 1567 (m), 1489 (w), 1448 (sh), 1430
(w), 1372 (w), 1364 (sh), 1344 (w), 1319 (w), 1273 (vw), 1245
(vw), 1201 (vw), 1171 (w), 1151 (vs), 1103 (vw), 1094 (vw), 980
(vw), 976 (vw), 832 (w), 823 (w), 816 (m), 798 (w), 768 (vw), 745
(s), 707 (m), 698 (w), 666 (w), 624 (m), 616 (s), 592 (vw), 545
(vw) cm−1. ESI-MS (pos.) m/z (%): 307.1 [M+]+ (100).
1-(4-(1-Adamantyl)phenyl)-1H-imidazolium iodide (10) was
prepared from compound 9 (0.1829 g, 0.66 mmol) to yield a
colorless powder (0.1246 g, 0.30 mmol, yield 45%). Mp: 194−196
°C. Anal. Calcd for C20H215IN2: C, 57.15; H, 5.99; N, 6.66. Found: C,
57.07; H, 5.93; N; 6.82. H NMR (CDCl3, 500 MHz): δ 10.52 (s,
1H), 7.54−7.68 (m, 5H), 7.53 (m, 1H), 4.25 (s, 3H), 2.11 (um, 3H),
1.89 (m, 6H), 1.77 (m, 6H). 13C{1H} NMR (CDCl3, 126 MHz): δ
154.3, 136.3, 132.0, 127.4, 124.6, 121.9, 120.9, 43.1, 37.7, 36.7, 36.6,
28.9. IR (KBr): 6453 (sh), 3404 (sh), 3148 (w), 3095 (sh), 3072
(m), 3044 (sh), 3005 (sh), 2928 (sh), 2911 (sh), 2900 (vs), 2885
(sh), 2847 (vs), 2679 (vw), 2656 (vw), 1571 (m), 1551 (m), 1516
(sh), 1508 (w), 1499(w), 1412 (vw), 1384 (w), 1369 (vw), 1359
(vw), 1343 (w), 1317 (vw), 1310 (sh), 1272 (vw), 1251 (vw), 1235
(vw), 1220 (w), 1107 (vw), 1103 (vw), 1077 (w), 1069 (sh), 1033
(vw), 1024 (vw), 1017 (vw), 1013 (vw), 978 (vw), 975(sh), 956
(vw), 938 (vw), 850 (vw), 841 (w), 809 (m), 727 (vw), 657 (vw),
641 (vw), 627 (sh), 614 (w), 610 (w), 564 (w), 551 (w) cm−1. ESI-
MS (pos.) m/z (%): 293.2 [M+]+ (100).
1-(4-(1-Adamantyl)phenyl)-1H-imidazole (9) was prepared
using a modified literature procedure.48 A brown dispersion of 8
(0.9955 g, 4.40 mmol), MeOH (32 mL), and 40% glyoxal solution
(185 μL, 1.62 mmol) was stirred for 19 h at room temperature. Then
NH4Cl (0.4705 g, 8.80 mmol) and a 37% HCHO solution (0.704 mL,
8.87 mmol) were added, and the reaction mixture was refluxed for 1 h
using an oil bath. After the reaction mixture cooled to room
temperature, concd H3PO4 (0.616 mL, 85%) was slowly added and
then the mixture was refluxed for 19 h. The solvent was evaporated,
the remaining oil was poured on an ice−water mixture, and the pH
was adjusted with 40% KOH solution to 10. This mixture was
extracted with AcOEt (5 × 30 mL), the combined organic phases
were washed with brine, and the solution was dried with Na2SO4
before evaporating the solvent under the reduced pressure. The
afforded mixture was purified by column chromatography (silica gel,
AcOEt/MeOH, 8:1, v-v) and obtained a crude product (Rf = 0.47)
that was purified by column chromatography (silica gel, AcOEt) to
yield a brown powder (0.1913 g, 0.69 mmol, yield 42%). Mp: 116−
118 °C. Anal. Calcd for C19H22N2: C, 81.97; H, 7.97; N, 10.06.
1
Found: C, 81.72; H, 8.12; N, 9.93. H NMR (CDCl3, 500 MHz): δ
8.27 (s, 1H), 7.50 (m, 2H), 7.38 (m, 2H), 7.32 (s, 1H), 7.31 (s, 1H),
2.13 (um, 3H), 1.93 (m, 6H), 1.79 (m, 6H). 13C{1H} NMR (CDCl3,
126 MHz): δ 152.2, 135.0, 134.2, 127.4, 126.8, 121.7, 119.1, 43.3,
36.8, 36.4, 29.0. IR (KBr): 3122 (w), 3114 (sh), 3059 (vw), 3040
(vw), 2941 (sh), 2928 (s), 2918 (sh), 2910 (vs), 2898 (sh), 2852
(m), 2845 (sh), 1610 (w), 1584 (vw), 1526 (s), 1518 (sh), 1509 (sh),
1490 (m), 1449 (w), 1371 (vw), 1345 (w), 1306 (m), 1266 (vw),
1257 (m), 1255 (sh), 1245 (w), 1110 (w), 1102 (w), 1057 (m), 1034
(w), 964 (w), 904 (w), 847 (w), 827 (w), 806 (m), 734 (w), 726 (w),
721 (w), 658 (sh), 656 (m), 652 (sh), 623 (vw), 552 (w) cm−1. ESI-
MS (pos.) m/z (%): 279.1 [M + H+]+ (100), 301.1 [M + Na+]+ (15),
557.3 [2·M + H+]+ (23), 579.4 [2·M + Na+]+ (15).
General Procedure toward Imidazolium Salts 5a, 5b, and 10.
Iodomethane (5 equiv, 0.95−3.30 mmol) was added into a solution of
imidazole 4a, 4b, or 9 (1 equiv, 0.19−0.66 mmol) in dry toluene (5
mL) under an inert atmosphere. The reaction mixture was stirred at
room temperature and monitored using TLC until the starting
imidazole disappeared. Then dry Et2O (2 mL) was added to
precipitate the imidazolium salt. The solid material was washed five
times with dry Et2O using a centrifuge. Dispersion in Et2O was
transferred into a round-bottom flask and solvent was evaporated to
obtain pure imidazolium salt, which was dried in a vacuum to
constant weight prior to supramolecular studies.
(4-(1-Adamantyl)phenyl)trimethylammonium iodide (11) was
prepared following a modified literature procedure.5b A mixture of 8
(0.1030 g, 0.45 mmol), NaHCO3 (0.0840 g, 1.00 mmol), CH3I
(0.205 mL, 3.30 mmol) and MeOH (32 mL) was refluxed for 8 h
using an oil bath. Then, the second portion of MeI (0.205 mL, 3.30
mmol) was added and the reaction mixture was refluxed for additional
8 h. The mixture was cooled down, concentrated under reduced
pressure and washed with hot acetone (20 mL) to obtain a white
solid. The solid crude product was washed with several portions of
CHCl3 to separate 11 from inorganic salts, and a yellowish powder
was obtained after evaporation of the solvent (0.1069 g, 0.26 mmol,
yield 59%). Mp: 186−188 °C. Anal. Calcd for C19H28IN: C 57.43, H
1
7.10, N 3.53 (%). Found C 57.31, H 7.12, N 3.49 (%). H NMR
(DMSO-d6, 500 MHz): δ 7.89 (d, 2H, J = 9 Hz), 7.59 (d, 2H, J = 9
Hz), 3.60 (s, 9H), 2.07 (brs, 3H), 1.88 (um, 6H), 1.75 (um, 6H).
13C{1H} NMR (DMSO-d6, 126 MHz): δ 152.7, 144.8, 126.3, 120.0,
56.4, 42.2, 35.9, 35.8, 28.1. IR (KBr): 3446 (s), 3016 (w), 3005 (sh),
1-(4-(1-Adamantyl)benzyl)-1H-imidazolium iodide (5a) was
prepared from compound 4a (0.0839 g, 0.29 mmol) to yield a
4493
J. Org. Chem. 2021, 86, 4483−4496